Multi-omics data compendium of pancreatic islet and β cell responses to pro-inflammatory cytokines

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

In type 1 diabetes (T1D), autoimmune responses and inflammation cause the death of pancreatic β cells, leading to the body’s inability to produce insulin and maintain glucose homeostasis. This process is at least in part mediated by pro-inflammatory cytokines, such as interferon (IFN)α, IFNγ, interleukin (IL)-1β, and tumor necrosis factor (TNF)α, which induce β-cell dysfunction and apoptosis. A deep understanding of the β-cell signaling and regulatory networks induced by these cytokines could lead to the identification of therapeutic targets to prevent T1D development. To study cytokine-mediated islets/β-cell signaling and regulatory networks, a variety of omics experiments have been conducted, including transcriptomics, epigenomics (DNA methylation, UMI-4C, ATAC-seq and ChIP-seq), proteomics (bottom-up, top-down, post-translational modification analysis), lipidomics, and metabolomics. The combination of these datasets can be instrumental in identifying signaling components and regulatory factors involved in β-cell stress/death. Here, we aggregated 51 (multi-)omics datasets from 19 studies spanning 14 years into a centralized location, providing a quality-controlled, statistically rigorous resource for investigators seeking to holistically study the impact of pro-inflammatory cytokines on β-cell fate.

Article activity feed